Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction
Yue Chen(Cedars-Sinai Medical Center), Yufei Yang(Hainan University), Yu Xu(Ministry of Public Security of the People's Republic of China), Tong Zhang(Capital Medical University), Lei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiawei Zhai(Jilin University), Haijun Jiang(Xinjiang Normal University)
Cited by 3
Related Papers
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
|Molecular Cell|2006|1.5k
Acetylation Is Indispensable for p53 Activation
|Cell|2008|828
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|204
Molecular Characterization of Propionyllysines in Non-histone Proteins
|Molecular & Cellular Proteomics|2008|167
In vitro and in vivo antioxidant effects of the ethanolic extract of Swertia chirayita
|Journal of Ethnopharmacology|2011|141